Cargando…
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Boosting natural immunity against malignant cells has had a major breakthrough in clinical cancer therapy. This is mainly due to the successful development of immune checkpoint blocking antibodies, which release a break on cytolytic anti-tumor-directed T-lymphocytes. However, immune checkpoint block...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309238/ https://www.ncbi.nlm.nih.gov/pubmed/30627131 http://dx.doi.org/10.3389/fimmu.2018.03081 |